Relmada Therapeutics Inc
(STU:4E2)
€
0.59
+0.065 (+12.38%)
Market Cap: 20.33 Mil
Enterprise Value: -2.72 Mil
PE Ratio: 0
PB Ratio: 0.97
GF Score: 41/100 Relmada Therapeutics Inc (STU:4E2) Transcripts
- 1